Ceritinib + Ulipristal Acetate [For uterine fibroids]
This interaction is documented in this data source.
- Ceritinib
- Checked as Ceritinib
- Ulipristal Acetate [For uterine fibroids]
- Checked as Ulipristal
What is documented
-
Others
Moderatevia Ceritinib and Ulipristal
What happens
Based on in vitro inhibition data, coadministration with ulipristal may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is decreased clearance in the intestine, liver, and/or kidney due to inhibition of P-glycoprotein-mediated drug efflux by ulipristal.
What to do
Caution is advised when ulipristal is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever ulipristal is added to or withdrawn from therapy.
1 source
- "Product Information. ella (ulipristal)." Afaxys Inc., Charleston, SC.